Impact of Digoxin on Mortality in Patients With Atrial Fibrillation Stratified by Heart Failure: Findings From Gulf Survey of Atrial Fibrillation Events in the Middle East

Conclusions:
In patients with AF and HF, digoxin did not offer any survival advantages. However, in those without HF, digoxin therapy was, in fact, associated with significantly higher long-term mortality.

Source: Journal of Cardiovascular Pharmacology and Therapeutics - April 9, 2016 Category: Cardiology Authors: Al-Zakwani, I., Panduranga, P., Zubaid, M., Sulaiman, K., Rashed, W. A., Alsheikh-Ali, A. A., AlMahmeed, W., Shehab, A., Al Qudaimi, A., Asaad, N., Amin, H. Tags: Clinical Studies Source Type: research